Sealantium Medical Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 4

Sealantium Medical General Information


Developer of bi-component hemostatic & sealing products designed to control severe bleeding and seal leakages during and post-surgery. The company's products specializes in developing bi-component hemostatic and sealing product composed of a polymeric film with a biological sealant and it includes fibrin sealant, enabling doctors to control hemorrhages.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Hagavish 4a
  • Netanya
  • Israel

Sealantium Medical Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sealantium Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 15-Oct-2018 $10M 000.00 Completed Generating Revenue
3. Grant 28-Nov-2017 00.000 00.000 Completed Generating Revenue
2. Later Stage VC 25-Jan-2017 $1.25M $1.25M 00.000 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Sealantium Medical’s complete valuation and funding history, request access »

Sealantium Medical Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A1 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Sealantium Medical’s complete cap table history, request access »

Sealantium Medical Executive Team (1)

Name Title Board Seat Contact Info
Orgad Laub Founder & Chief Executive Officer
To view Sealantium Medical’s complete executive team members history, request access »

Sealantium Medical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sealantium Medical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avv Investment Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Everett Partners Venture Capital Minority 000 0000 000000 0
Targetech Innovation Center Accelerator/Incubator 000 0000 000000 0
To view Sealantium Medical’s complete investors history, request access »